Susquehanna Fundamental Investments’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-54,993
Closed -$465K 665
2025
Q4
$465K Sell
54,993
-65,279
-54% -$466K 0.02% 437
2025
Q3
$628K Sell
120,272
-158,940
-57% -$606K 0.02% 406
2025
Q2
$966K Sell
279,212
-76,953
-22% -$229K 0.03% 452
2025
Q1
$933K Buy
356,165
+9,877
+3% +$38.7K 0.02% 706
2024
Q4
$1.43M Buy
+346,288
New +$1.88M 0.02% 619
2024
Q2
$348K Buy
53,442
+38,117
+249% +$260K 0.01% 760
2024
Q1
$127K Buy
+15,325
New +$150K 0.01% 644
2022
Q4
Sell
-12,401
Closed -$277K 1437
2022
Q3
$277K Buy
+12,401
New +$272K ﹤0.01% 1180
2022
Q1
$211K Buy
+7,051
New +$171K ﹤0.01% 1352
2021
Q4
Sell
-7,300
Closed -$230K 1717
2021
Q3
$230K Buy
+7,300
New +$246K ﹤0.01% 1494
2021
Q2
Sell
-11,548
Closed -$399K 1759
2021
Q1
$399K Sell
11,548
-20,322
-64% -$882K 0.01% 1217
2020
Q4
$1.32M Sell
31,870
-7,037
-18% -$318K 0.02% 759
2020
Q3
$1.66M Buy
+38,907
New +$1.48M 0.05% 492

Other funds holding RLAY